Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
ID: 349480Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $275K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life" (R21 Clinical Trial Optional) aimed at fostering research on the relationship between social disconnection and suicidal thoughts among older adults. This initiative encourages researchers to investigate neurobiological, behavioral, and environmental mechanisms that contribute to suicide risk and resilience, with a focus on health equity and disparities. The funding supports exploratory projects without preliminary data, offering up to $275,000 over two years, with applications due by September 7, 2026. Interested applicants from eligible organizations can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a Notice of Funding Opportunity (NOFO) titled "Social Disconnection and Suicide Risk in Late Life" (R21 Clinical Trial Optional), designed to spur research into the correlation between social disconnection and suicidal thoughts in older adults. Researchers are encouraged to explore mechanisms at various analytical levels—neurobiological, behavioral, and environmental—that affect suicide risk and resilience while considering health equity and disparities. The funding supports exploratory projects that lack preliminary data, with a budget of up to $275,000 over two years. Applicants must come from eligible organizations, including educational institutions, nonprofits, and government entities, and they need to complete various registrations before applying. The application process requires detailed design plans, adherence to rigorous ethical standards for research with human subjects, and a commitment to share research data post-study. Key deadlines include submission dates starting September 16, 2023, with awards expected to begin after thorough peer review. This initiative addresses rising suicide rates among older populations and the urgent need for effective interventions that leverage social connectivity for mental health support.
    Similar Opportunities
    Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)" aimed at stimulating research on the relationship between social disconnection, including both objective social isolation and perceived loneliness, and suicide risk among older adults. The initiative seeks applications for research projects that explore neurobiological and environmental mechanisms contributing to suicidal thoughts and behaviors in late life, with a focus on developing and testing interventions to enhance social connection and prevent suicide. This funding opportunity is particularly significant given the rising suicide rates in the aging population, exacerbated by social isolation, and encourages innovative research methodologies to address these mental health challenges. Interested applicants can find more details and submit their proposals by the closing date of September 7, 2026, and should direct inquiries to grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-238.html.
    Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Research Opportunities in Crisis Response Services for Suicide Prevention," aimed at supporting exploratory research into the effectiveness and implementation of crisis response services designed to prevent suicides. This initiative seeks to evaluate the impact of state and local policies on crisis service outcomes, focusing on real-world applications that consider various factors such as clinical presentations, geographic settings, cultural considerations, and health disparities. The total funding available is $2 million across fiscal years 2025-2026, with individual project budgets capped at $225,000 per year for a maximum of three years. Interested applicants can find more information and submission guidelines at the NIH grants website and should direct inquiries to grantsinfo@nih.gov. The application deadline is June 2, 2025.
    Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)" aimed at supporting formative research and pilot testing of culturally sensitive interventions to address suicidal ideation and non-suicidal self-injury in low- and middle-income countries (LMICs). The initiative seeks to strengthen research capacity within the LMIC communities and requires applicants to conduct pilot studies that assess the feasibility, acceptability, and costs of proposed interventions. With an estimated total program funding of $2 million available for up to 8 awards, applicants can request direct costs of up to $225,000 per year for a maximum of three years. Interested parties must submit their applications by January 25, 2025, with the opportunity closing on October 24, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-160.html.
    Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)" aimed at advancing research on crisis response services related to suicide prevention. This initiative seeks proposals that examine the impact of state and local policies on the implementation and outcomes of crisis response services, particularly in the context of the 988 rollout, while considering various demographic and psychosocial factors. The program emphasizes the importance of real-world research settings and encourages community collaborations to enhance the practical application of findings. Up to $2,000,000 is available for this initiative, with the intention of awarding approximately 3-5 grants annually over a potential project period of up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with the application window opening on September 1, 2024, and the close date set for June 2, 2025.
    Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Schizophrenia and Related Disorders During Mid- to Late-Life" (PAR-24-026), aimed at advancing research on the onset and progression of schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to promote high-risk exploratory and developmental projects that investigate neurobiological, psychosocial, and environmental factors contributing to these disorders, with a particular emphasis on addressing health disparities among minority and aging populations. The program offers a maximum funding amount of $275,000 over two years, with applications due by November 16, 2023, for the initial cycle. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings," aimed at evaluating the effectiveness of interventions that promote the safe storage of potentially lethal means, such as firearms and medications, for individuals at increased risk of suicide. This initiative, through the National Institute of Mental Health (NIMH), seeks applications for R34 Planning Grants to conduct pilot effectiveness research on lethal means safety strategies, which have shown promise in reducing suicide attempts but require further evidence in healthcare and community settings. The total funding available is $1.5 million, with up to six grants awarded, each with a maximum budget of $450,000 over three years. Interested applicants must submit their proposals by June 15, 2024, for an initial review in November 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)" aimed at advancing research on schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to explore the mechanisms, trajectories, and outcomes of these disorders, with a focus on identifying targets for prevention and treatment interventions, particularly emphasizing the inclusion of diverse research teams and individuals with lived experience. The funding is available through the R01 grant mechanism, with applications due by September 7, 2026, and interested applicants are encouraged to adhere strictly to the application guidelines and contribute data to the National Institute of Mental Health Data Archive. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-023.html.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders" (R61/R33 Clinical Trial Required). This initiative aims to support pilot research that develops and tests innovative psychosocial interventions targeting mental disorders in both adults and children, focusing on early-stage exploratory clinical trials to assess how these interventions engage biological, cognitive, or behavioral targets linked to mental health issues. Successful projects will receive funding for up to two years in the R61 phase for preliminary studies, with the potential for an additional three years in the R33 phase contingent upon meeting specified milestones. Interested applicants must adhere to strict guidelines regarding human subject protections and submit their applications through Grants.gov by the deadline of October 15, 2024. For further inquiries, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for the Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). This initiative aims to support pilot research focused on innovative psychosocial intervention strategies for both adults and children, emphasizing the experimental therapeutic approach to address underlying mechanisms of mental disorders. The funding will facilitate exploratory clinical trials for up to three years, with no specific budget limits, provided they reflect actual project needs, and applications must demonstrate a strong scientific rationale and empirical support. Interested applicants can find more information and application details at the provided NIH link, with a submission deadline of October 15, 2024.
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)," aimed at supporting studies that address barriers to the adoption and sustainability of evidence-based health interventions, particularly in underserved communities. The initiative encourages research that promotes equitable access to effective practices and explores methods for discontinuing ineffective or harmful interventions, emphasizing the importance of contextual factors and multidisciplinary collaboration. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $275,000 and a project period of up to two years. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by May 7, 2025.